The Impact of Exacerbation Frequency on Clinical and Economic Outcomes in Swedish COPD Patients: The ARCTIC Study

被引:10
|
作者
Larsson, Kjell [1 ]
Janson, Christer [2 ]
Lisspers, Karin [3 ]
Stallberg, Bjorn [3 ]
Johansson, Gunnar [3 ]
Gutzwiller, Florian S. [4 ]
Mezzi, Karen [4 ]
Bjerregaard, Bine Kjoeller [5 ]
Jorgensen, Leif [5 ]
机构
[1] Karolinska Inst, Natl Inst Environm Med, Integrat Toxicol, SE-17177 Stockholm, Sweden
[2] Uppsala Univ, Dept Med Sci Resp Allergy & Sleep Res, Uppsala, Sweden
[3] Uppsala Univ, Dept Publ Hlth & Caring Sci, Family Med & Prevent Med, Uppsala, Sweden
[4] Novartis Pharma AG, Global Patient Access, Basel, Switzerland
[5] IQVIA Solut, Real World Evidence Solut, Copenhagen, Denmark
来源
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2021年 / 16卷
关键词
chronic obstructive pulmonary disease; exacerbations; mortality; lung function; healthcare cost; Sweden; OBSTRUCTIVE PULMONARY-DISEASE; MANAGEMENT; DIAGNOSIS; MORTALITY; OVERLAP; DECLINE;
D O I
10.2147/COPD.S297943
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Purpose: The aim of this study was to assess the association between exacerbation frequency and clinical and economic outcomes in patients with COPD. Patients and Methods: Electronic medical record data linked to National Health Registries were collected from COPD patients at 52 Swedish primary care centers (2000-2014). The outcomes analyzed were exacerbation rate, mortality, COPD treatments, lung function and healthcare costs during the follow-up period. Based on the exacerbation rate two years before index date, the patients were initially classified into three groups, either 0, 1 or >= 2 exacerbations per year. After the index date, the classification into exacerbation groups was updated each year based on the exacerbation rate during the last year of follow-up. A sensitivity analysis was conducted excluding patients with asthma diagnosis from the analysis. Results: In total 18,586 COPD patients were analyzed. A majority of the patients (60-70%) who either have had no exacerbation or frequent exacerbations (>= 2/year) during the preindex period remained in their group (ie, with 0 or >= 2 annual exacerbations) during up to 11 years of follow-up. Compared with having no exacerbation, mortality was higher in patients having 1 (HR; 2.06 [1.93-2.201) and >= 2 (4.58 [4.33-4.841) exacerbations at any time during the follow-up. Lung function decline was more rapid in patients with frequent exacerbations and there was an almost linear relationship between exacerbations frequency and mortality. Total healthcare costs were higher in the frequent exacerbation group (>= 2/year) than in patients with no or one exacerbation annually (p<0.0001 for both). The results did not differ from the main analysis after exclusion of patients with a concurrent asthma diagnosis. Conclusion: In addition to faster lung function decline and increased mortality, frequent exacerbations in COPD patients imply a significant economic burden.
引用
收藏
页码:701 / 713
页数:13
相关论文
共 50 条
  • [31] Impact of hyponatraemia during exacerbation on clinical outcomes in patients with bronchiectasis
    Kwok, W. C.
    Yap, D. Y. H.
    Tam, T. C. C.
    Lam, D. C. L.
    Ip, M. S. M.
    Ho, J. C. M.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2024, 28 (11)
  • [32] THE ECONOMIC IMPACT OF OPTIMIZED POST-HOSPITALIZATION MANAGEMENT FOR AN EXACERBATION IN COPD PATIENTS IN CHINA
    Salem, A.
    Ramos, M.
    Hu, H.
    Zhong, H.
    Lamotte, M.
    VALUE IN HEALTH, 2018, 21 : S409 - S409
  • [33] ECONOMIC IMPACT OF AVOIDABLE DRUG WASTAGE IN PATIENTS ADMITTED TO THE HOSPITAL FOR AN ACUTE COPD EXACERBATION
    Bollu, V
    Clark, R. S.
    Carlton, R.
    Meyer, K. L.
    VALUE IN HEALTH, 2015, 18 (03) : A172 - A172
  • [34] Impact of Cirrhosis on Patients Admitted With Acute COPD Exacerbation: A Nationwide Study
    Obeidat, Adham
    Yassine, Ahmad Abou
    Aldiabat, Mohammad
    Mahfouz, Ratib
    Holman, George
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1375 - S1375
  • [35] Relationship Between Exacerbation Frequency And Clinical Outcomes In Patients With Cystic Fibrosis
    de Boer, K.
    Vandemheen, K. L.
    Tullis, E.
    Doucette, S.
    Fergusson, D.
    Freitag, A.
    Paterson, N.
    Jackson, M.
    Lougheed, M. D.
    Kumar, V.
    Aaron, S. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [36] ORIGINAL RESEARCH Impact of Coexisting Dementia on Inpatient Outcomes for Patients Admitted with a COPD Exacerbation
    Gupta, Ayushman
    McKeever, Tricia M.
    Hutchinson, John P.
    Bolton, Charlotte E.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 17 : 535 - 544
  • [37] No association between exacerbation frequency and stroke in patients with COPD
    Windsor, Claire
    Herrett, Emily
    Smeeth, Liam
    Quint, Jennifer Kathleen
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 217 - 225
  • [38] Characteristics and outcomes of diabetic patients with acute exacerbation of COPD
    Monsour, Elio
    Rodriguez, Lyd-Marie
    Abdelmasih, Randa
    Tuna, Kubra
    Abusaada, Khalid
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2021, 20 (01) : 461 - 466
  • [39] Impact of COPD Exacerbation Frequency on Costs for a Managed Care Population
    Dalal, Anand A.
    Patel, Jeetvan
    D'Souza, Anna
    Farrelly, Eileen
    Nagar, Saurabh
    Shah, Manan
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (07): : 575 - U108
  • [40] Clinical characteristics and determinants of exacerbation in Japanese patients with COPD: Hokkaido COPD cohort study results
    Suzuki, Masaru
    Makita, Hironi
    Konno, Satoshi
    Shimizu, Kaoruko
    Taniguchi, Natsuko
    Ito, Yoichi M.
    Nishimura, Masaharu
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40